Dyatlov I, Svetoch E, Mironenko A, Eruslanov B, Firstova V, Fursova N
Vaccines (Basel). 2022; 10(11).
PMID: 36366362
PMC: 9692684.
DOI: 10.3390/vaccines10111854.
Shaka M, Arias-Rojas A, Hrdina A, Frahm D, Iatsenko I
PLoS Pathog. 2022; 18(9):e1010825.
PMID: 36084158
PMC: 9491580.
DOI: 10.1371/journal.ppat.1010825.
Ali A, An S, Cui C, Haque A, Carbis R
Hum Vaccin Immunother. 2014; 10(6):1494-8.
PMID: 24603090
PMC: 5396222.
DOI: 10.4161/hv.28130.
Oftung F, Naess L, Wetzler L, Korsvold G, Aase A, Hoiby E
Infect Immun. 1999; 67(2):921-7.
PMID: 9916109
PMC: 96405.
DOI: 10.1128/IAI.67.2.921-927.1999.
Naess L, Oftung F, Aase A, Wetzler L, Sandin R, Michaelsen T
Infect Immun. 1998; 66(3):959-65.
PMID: 9488382
PMC: 108002.
DOI: 10.1128/IAI.66.3.959-965.1998.
Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide.
Colino J, Outschoorn I
Infect Immun. 1998; 66(2):505-13.
PMID: 9453603
PMC: 107935.
DOI: 10.1128/IAI.66.2.505-513.1998.
Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.
Alberti S, Alvarez D, Merino S, Casado M, Vivanco F, Tomas J
Infect Immun. 1996; 64(11):4726-32.
PMID: 8890232
PMC: 174438.
DOI: 10.1128/iai.64.11.4726-4732.1996.
Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36.
Alberti S, Marques G, Rubires X, Tomas J, Vivanco F, Benedi V
Infect Immun. 1996; 64(11):4719-25.
PMID: 8890231
PMC: 174437.
DOI: 10.1128/iai.64.11.4719-4725.1996.
Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.
Konadu E, Shiloach J, Bryla D, Robbins J, Szu S
Infect Immun. 1996; 64(7):2709-15.
PMID: 8698499
PMC: 174130.
DOI: 10.1128/iai.64.7.2709-2715.1996.
Monoclonal antibodies to Coxiella burnetii that cross-react with strain Nine Mile.
Sekeyova Z, Kovacova E, Kazar J, Toman R, Olvecka S
Clin Diagn Lab Immunol. 1995; 2(5):531-4.
PMID: 8548530
PMC: 170195.
DOI: 10.1128/cdli.2.5.531-534.1995.
C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.
Alberti S, Marques G, Camprubi S, Merino S, Tomas J, Vivanco F
Infect Immun. 1993; 61(3):852-60.
PMID: 8432605
PMC: 302811.
DOI: 10.1128/iai.61.3.852-860.1993.
Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease.
Guttormsen H, Wetzler L, Naess A
Infect Immun. 1993; 61(11):4734-42.
PMID: 8406872
PMC: 281228.
DOI: 10.1128/iai.61.11.4734-4742.1993.
Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease.
Guttormsen H, Wetzler L, SOLBERG C
Infect Immun. 1994; 62(4):1437-43.
PMID: 8132350
PMC: 186299.
DOI: 10.1128/iai.62.4.1437-1443.1994.
Immunochemical and antigenic characterization of Coxiella burnetii strains isolated in Europe and Mongolia.
Kovacova E, Vavrekova M, Lukacova M, DAITER A, Tokarevich N, Karceva N
Eur J Epidemiol. 1994; 10(1):9-15.
PMID: 7957797
DOI: 10.1007/BF01717445.
Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines.
Konadu E, Robbins J, Shiloach J, Bryla D, Szu S
Infect Immun. 1994; 62(11):5048-54.
PMID: 7927787
PMC: 303225.
DOI: 10.1128/iai.62.11.5048-5054.1994.
Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burst.
Bjerknes R, Guttormsen H, SOLBERG C, Wetzler L
Infect Immun. 1995; 63(1):160-7.
PMID: 7806353
PMC: 172973.
DOI: 10.1128/iai.63.1.160-167.1995.
Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Haemophilus influenzae.
Gu X, Tsai C, Apicella M, Lim D
Infect Immun. 1995; 63(10):4115-20.
PMID: 7558327
PMC: 173578.
DOI: 10.1128/iai.63.10.4115-4120.1995.
Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.
Gupta R, Egan W, Bryla D, Robbins J, Szu S
Infect Immun. 1995; 63(8):2805-10.
PMID: 7542631
PMC: 173380.
DOI: 10.1128/iai.63.8.2805-2810.1995.
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.
Szu S, Stone A, ROBBINS J, Schneerson R, Robbins J
J Exp Med. 1987; 166(5):1510-24.
PMID: 3681191
PMC: 2189650.
DOI: 10.1084/jem.166.5.1510.
Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever.
Stone A, Szu S
J Clin Microbiol. 1988; 26(4):719-25.
PMID: 3366868
PMC: 266426.
DOI: 10.1128/jcm.26.4.719-725.1988.